Refractory Rare Malignant Solid Neoplasm
1 clinical trials · Condition
◉ Watch Refractory Rare Malignant Solid Neoplasm
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial (NCT05715281) | National Cancer Institute (NCI) | 2023-09-26 |
Track Refractory Rare Malignant Solid Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.